title: Reply to the letter to the editor: symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors.
authors.affiliation: Orthopaedic Surgery at the Rothman Institute, Thomas Jefferson University Hospital, 125 S 9th St. Ste 1000, Philadelphia, PA, 19107, USA, research@rothmaninstitute.com.
authors.forename: Javad
authors.initials: J
authors.lastname: Parvizi
authors.forename: Ronald
authors.initials: R
authors.lastname: Huang
authors.forename: Ibrahim J
authors.initials: IJ
authors.lastname: Raphael
authors.forename: William V
authors.initials: WV
authors.lastname: Arnold
authors.forename: Richard H
authors.initials: RH
authors.lastname: Rothman
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D019643:Arthroplasty, Replacement / Q000009:adverse effects*; D001241:Aspirin / Q000627:therapeutic use*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011655:Pulmonary Embolism / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D014859:Warfarin; D001241:Aspirin